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Abstract
Background: Given the relative abundance and toxic potential of acrolein in inhaled cigarette smoke, it is surprising how
little is known about the pulmonary and systemic effects of acrolein. Here we test the hypothesis whether systemic
administration of acrolein could cause endoplasmic reticulum (ER) stress, and lung cell apoptosis, leading to the
enlargement of the alveolar air spaces in rats.
Methods: Acute and chronic effects of intraperitoneally administered acrolein were tested. Mean alveolar airspace area was
measured by using light microscopy and imaging system software. TUNEL staining and immunohistochemistry (IHC) for
active caspase 3 and Western blot analysis for active caspase 3, and caspase 12 were performed to detect apoptosis. The ER-
stress related gene expression in the lungs was determined by Quantitative real-time PCR analysis. Acrolein-protein adducts
in the lung tissue were detected by IHC.
Results: Acute administration of acrolein caused a significant elevation of activated caspase 3, upregulation of VEGF
expression and induced ER stress proteins in the lung tissue. The chronic administration of acrolein in rats led to
emphysematous lung tissue remodeling. TUNEL staining and IHC for cleaved caspase 3 showed a large number of apoptotic
septal cells in the acrolein-treated rat lungs. Chronic acrolein administration cause the endoplasmic reticulum stress
response manifested by significant upregulation of ATF4, CHOP and GADd34 expression. In smokers with COPD there was
a considerable accumulation of acrolein-protein adducts in the inflammatory, airway and vascular cells.
Conclusions: Systemic administration of acrolein causes endoplasmic reticulum stress response, lung cell apoptosis, and
chronic administration leads to the enlargement of the alveolar air spaces and emphysema in rats. The substantial
accumulation of acrolein-protein adducts in the lungs of COPD patients suggest a role of acrolein in the pathogenesis of
emphysema.
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Introduction
Both active cigarette smoking and chronic exposure to cigarette
smoke of non-smokers in enclosed environments, so-called second
hand smoke exposure, cause heart and lung diseases in susceptible
individuals [1–4]. Inhalation of cigarette smoke introduces
exogeneous reactive oxidants into the airways and also causes
generation of endogenous oxidants released from phagocytes and
other cells in the lungs [5,6]. It has been long appreciated that
cigarette smoke contains particles, volatile components and
endotoxin [7,8] and that a multitude of individual smoke
components, or interactions between a number of these compo-
nents, are responsible for the chronic respiratory bronchiolitis [9]
and emphysematous destruction [10] of the lung. Stedman
reported 40 years ago that cigarette smoke is comprised of more
than 4700 chemicals [11] and therefore many investigators
consider it a somewhat futile exercise to investigate which of these
cigarette smoke components cause inflammation and lung tissue
damage. Although the burning cigarette may also be an antigen
delivery device [10], there may be chemicals which, when inhaled,
have cytotoxic and genotoxic effects. One such compound inhaled
with the cigarette smoke is the highly aggressive aldehyde acrolein.
Depending on the brand of the cigarette 200–400 mg of this
volatile aldehyde are inhaled with the smoke generated by a single
cigarette [12]. The ‘dosing’ of aldehyde to the lung is not restricted
to the airways via inhalation, because acrolein also appears in the
blood of smokers and is excreted in the urine [13]. Systemic effects
of acrolein are likely also to occur following uptake via the
gastrointestinal tract. Acrolein forms protein – and DNA-adducts
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lipids [17]. Of interest, acrolein, like ceramide [18,19], is also an
endogenous metabolic product produced by activated neutrophils
[20,21]. Acrolein has been shown to induce the release of
cytokines from human macrophages, and elevated plasma levels of
acrolein can be measured as a byproduct of polyamine metabolism
in patients with renal failure [22,23]. Given the relative abundance
of acrolein in inhaled cigarette smoke and its recognized toxic
potential as a product of activated inflammatory cells, it is
surprising how little we know about the pulmonary effects of
systemic acrolein levels. We are aware of only one report by
Borchers et al. [24] demonstrating that inhalation of acrolein
caused lung inflammation and airspace enlargement in rats. An
important distinguishing feature of our present investigations is the
systemic administration of acrolein. This approach was taken in
order to model the effects of circulating acrolein on the rat lung.
Our data demonstrate that acute administration to acrolein
induced ER stress response gene expression and upregulated
VEGF protein in the lung tissue. The chronic exposure to acrolein
caused apoptosis of alveolar septal cells, downregulation of VEGF
protein expression and the development of emphysema. There was
a significant accumulation of acrolein-protein adducts in the lungs
of COPD patients suggestive of a role of acrolein in emphysema
pathogenesis. Our findings are important in the context of the
toxic effects of second hand smoke and provide evidence for a new
molecular mechanism of acrolein cytotoxicity in the lung tissue.
Results
Acute effects of systemic acrolein administration
To assess the acute effects of acrolein on the lung tissue we used
a single intraperitoneal injection of acrolein at a dose of 12 mmol/
kg in PBS. The rationale for the acute systemic dosing was to begin
to explore systemic (circulating) acrolein effects on the lung,
because heavy smokers have elevated blood levels of acrolein.
Animals were sacrificed at 1, 2, 4 and 24 hour(s) after the acrolein
injection. The levels of acrolein injected are compatible with
concentration of acrolein in mainstream smoke from one cigarette
that is directly exhaled from smoker after taking a puff on a lit
cigarette [25]. No inflammatory cell accumulation was observed in
any of the lungs. There was a significant increase of cleaved
caspase 3 protein in the lung tissue at 2 hours post i.p. injection
(Figure 1A) supporting the interpretation that acute systemic
administration of acrolein induced transient lung cell apoptosis. In
contrast, there was no increase in lung tissue cleaved caspase 12
(Figure 1B). One single injection of acrolein was followed by
a persistent increase in lung tissue VEGF protein expression
(Figure 1C). Similar effects of acrolein have been documented in
cultured endothelial cells treated with tunicamycin, a known
inducer of endoplasmic reticulum (ER) stress [26].
In order to investigate the acute effects of acrolein on signals
representing ER stress we chose the transcription factor ATF4,
BiP, a chaperone, CHOP- a transcription factor down-stream
from ATF4, Gadd 34 (growth arrest and DNA damage) which is
induced by a variety of stressors [27] and XBP-1 (X-box binding
protein-1) which has been associated with ER-stress-triggered
phospholipid biosynthesis. As shown in Figure 2 acrolein induced
a significant early upregulation of ATF4 and BIP transcripts and
later, at the 24 hours after injections resulted in significant
induction of CHOP and to a lesser degree of ARF4, BIP, Gadd34
and Spliced form of X-box binding protein-1 (XBP-1s) transcrip-
tion.
Systemic chronic administration of acrolein causes
airspace enlargement
To examine the effects of chronic systemic challenges with
acrolein on the integrity of the lung tissue we administered 3
different doses of acrolein once a week for 3 weeks.
When compared to control rat lungs (Figure 3A), the lungs from
rats treated with a single injection of acrolein (24 mmol/kg) once
a week for 3 consecutive weeks show diffuse airspace enlargement
(Figure 3B) without obvious inflammatory responses. As measured
by the mean alveolar airspace area, chronic systemic acrolein
induced a dose-dependent increase of airspace enlargement,
(Figure 3C).
Chronic acrolein treatment causes apoptosis of lung
alveolar septal cells
TUNEL staining performed to screen for the presence of
alveolar septal cells undergoing necrosis or apoptosis revealed, that
when compared to control lungs (Figure 4A), there were a large
number of labeled TUNEL+ cells in the lungs from acrolein-
injected animals (Figure 4B). The quantification of TUNEL data is
presented in Figure 4C.
Immunohistochemistry for caspase 3 expression showed that,
when compared to control lungs (Figure 5A), number of cells
positive for caspase 3 expression is much higher in acrolein-treated
rat lungs (Figure 5B). The apoptosis index based on caspase
+ cells
per 10 high power microscopic fields was greater in the 12 mmol/
kg acrolein-treated group when compared to the 6 mmol/kg-
treated group (Figure 5C). Of interest, the injection of the highest
dose of 24 mmol/kg of acrolein did not cause a further increase in
the number of caspase+ cells-perhaps indicating that at the time
the animals had been sacrificed this acrolein dose had caused cell
necrosis and fewer cells were undergoing apoptosis. The IHC data
were confirmed by Western blot analysis. Cleaved caspase 3
protein expression was increased in the lungs from animals treated
with the 12 mmol/kg dose of acrolein, but not the 24 mmol/kg
dose (Figure 5D).
Chronic acrolein treatment: VEGF and ER stress responses
in the lung
The VEGF protein expression in the lungs from acrolein treated
animals was assessed by Western blotting. There was a dose-
dependent decrease in the amount of lung tissue VEGF protein
levels (Figure 6A) that correlates with the loss of the lung structure
and the development of emphysema. This is in agreement with
previously published data of rat models of emphysema where lung
tissue VEGF protein loss has been reported [28]. Treatment with
12 and 24 mmol/kg acrolein injections also significantly increased
levels of active cleaved inflammatory caspase 12 (Figure 6B) when
compared to control or 6 mmol/kg acrolein treatment. Moreover,
chronic acrolein (12 mmol/kg) administration also resulted in
a statistically significant increase in the mRNA levels of the ER
stress response proteins ATF4, CHOP, and Gadd 34 (Figure 7) in
the lung tissue.
Acrolein-Protein adducts in COPD Patient lungs
We found marked staining in the lungs from patients with
COPD when using the antibody directed against acroleinated
proteins. As shown in Figure 8A–C, acroleinated proteins were
found in bronchoepithelial (A), endothelial and smooth muscle
cells of the small vessels (B) and inflammatory cells (C). Blue
arrowheads indicate tar deposition in smokers with COPD lungs.
The enlarged area from Figure 8C shows macrophages with
engulfed apoptotic bodies. The representative image reflects
Acrolein and Emphysema
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that acrolein-protein adducts contribute to the impairment of
macrophage function in emphysema. In contrast, in healthy lungs,
there we found very few inflammatory cells (arrows) staining
positive for acrolein-protein adducts (Figure 8D and 8E).
Discussion
The highly reactive aldehyde acrolein is a component of inhaled
cigarette smoke. Acrolein can be produced endogenously as
a metabolic product of activated inflammatory cells [22,29], and
cyclophosphamide-induced lung toxicity is possibly due to
acrolein-adduct formation [30]. Our study shows that acute
acrolein treatment increases VEGF gene and protein expression.
This effect declined with chronic treatment. Our findings are in
agreement with the reported elevation of VEGF in the sputum of
healthy smokers and with the decrease of both VEGF and VEGF
receptor expression in COPD and with the in vitro study by Volpi
et al demonstrating increased production of VEGF in pulmonary
smooth muscle cells and fibroblasts in response to cigarette smoke
extract, acrolein, crotonaldehyde and 4-HNE treatments [31].
Upregulation of VEGF production might reflect cells initial
defensive response against injury.
However, chronic administration of acrolein causes airspace
enlargement due to lung cell apoptosis and loss of lung tissue
VEGF expression. Interestingly, the acrolein-dependent lung cell
damage was not accompanied by inflammation. In addition, we
show that acrolein induces ER stress in the lung. In earlier studies
acrolein-induced ER/UPS stress has been documented only in the
cell cultures [32,33]. Although it has been generally accepted that
acrolein is toxic, we find only a single publication which
demonstrates that inhaled acrolein causes lung inflammation
characterized by macrophage and lymphocyte accumulation and
airspace enlargement [24]. The findings, presented here, are to
our knowledge the first data that show that systemic challenge with
acrolein causes activation of lung cells within hours of its injection,
and that multiple systemic injections cause a dose-dependent
airspace enlargement (Figure 3). Because the highest dose of
acrolein injected caused the most abundant increase of TUNEL+
cells, yet was associated with a less abundant labeling of activated
caspase 3+ cells, we speculate that this highest dose caused both
Figure 1. Acute effects of acrolein exposure. Western blot analysis of active cleaved caspase 3 (A), caspase 12 (B) and VEGF (C) in whole lung
tissue homogenates. WB bands were normalized to beta-actin. **P,0.01; *P,0.05 when compared to a control group. Rats received a single i.p.
injection of acrolein at 12 mmol/kg and were sacrificed 1, 2, 4 or 24 hours after the challenge. n=4 animals per group, data are mean6S.E.
doi:10.1371/journal.pone.0038038.g001
Figure 2. Quantitative real-time PCR analysis of the Unfolded
Protein Response (UPR)-related gene expression. Rats received
a single i.p. injection of acrolein at 12 mmol/kg and were sacrificed 1, 2,
4 or 24 hours after the challenge. n=4 animals per group, data are
mean6S.E.
doi:10.1371/journal.pone.0038038.g002
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undergo necrosis.
Acrolein induced pulmonary function changes in rats consistent
with emphysema have been reported by Costa et al [34]. Acrolein
effects on the lung were recently reviewed by Bein et al [29].
Acrolein was found in sputum and exhaled condensate from
COPD patients [35]. Acrolein has been shown to induce VEGF
[31] and GADD45 beta [36] transcripts as well as increase
apoptosis and inhibit VEGF mobilization [37,38]. There is a report
suggesting that glutathione conjugation effectively removes acro-
lein from external exposures such as cigarette smoke [39].
Apoptosis sensitivity or resistance to acrolein may be cell-type
specific; for example 100 mM acrolein caused neuronal cell death
after 4 hours [40], and cultured endothelial cells underwent
apoptosis when challenged with 10 mM of acrolein [41]. It has
been also reported that the antiangiogenic effects of the alkylating
chemotherapeutic drug cyclophosphamide are likely due to the
release of acrolein [42]. One limitation of our study is that we did
not measure tissue acrolein levels. However, we can assume that
sufficient amounts of acrolein reached the lung since there was
a significant lung tissue remodeling after chronic systemic
administration of acrolein.
Kelsen et al. [43] identified endoplasmic reticulum (ER) stress
and activation of the unfolded protein response in the lung tissue
from patients with COPD. Prompted by this report [43], we asked
whether acrolein exposure generates ER stress and triggers the
unfolded protein response in the lung tissue of acrolein-challenged
animals. To test whether the lung tissue from acrolein-treated
animals expressed markers of ER stress, we extracted RNA from
lung tissue at different intervals after the acute acrolein treatment
and screened for a panel of genes expressed during ER stress.
Proteins enter the ER as unfolded polypeptide chains and cells
adjust the protein folding capacity of the ER. Such homeostatic
control is achieved through the action of a signal transduction
pathway that utilizes sensors facing the ER lumen. ER stress
results in one of three responses: first, there is a reduction in the
protein load entering the ER; second, there is an increase in the
ER capacity to handle unfolded proteins and third, if homeostasis
cannot be achieved, cell death is triggered, perhaps to protect
organisms from cells which accumulate unfolded proteins [44]. In
search of signals representing ER stress we chose the transcription
factor ATF4, binding immunoglobulin protein BiP- (a chaperone),
cytosine-cytosine-adenine-adenine-thymine enhancer-binding pro-
tein homologous protein CHOP) (a transcription factor down-
stream from ATF4), Gadd 34 (growth arrest and DNA damage)
which is induced by a variety of stressors [27] and XBP-1 (X-box
binding protein-1) which has been associated with ER-stress-
triggered phospholipid biosynthesis.
Unregulated expression of the transcription factor CHOP
promotes cell death, and CHOP deletion protects against the
death of ER stressed cells. CHOP activates Gadd 34 and Gadd 34
deletion likewise protects against ER stress-induced cell death [27].
Our data show that acrolein induces ER stress, which can be
documented as early as 1 hour after acrolein injection (ATF4, BiP
and CHOP mRNA). Multiple acrolein injections, which were
associated with alveolar cell loss and airspace enlargement, caused
Figure 3. Histology of rat lungs. A. Section of a representative control rat lung showing normal alveolar structure. B. Section of a lung from
a2 4mmol/kg acrolein treated rat showing enlarged airspaces. Magnification: 256. Scale bars=100 mm. C. Emphysema in acrolein treated lungs
assessed by mean alveolar airspace area (mm
2). Data generated from n=4 animals/per group, values are mean6S.E. * P,0.05 compared with the
control group
doi:10.1371/journal.pone.0038038.g003
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markers, CHOP and Gadd 34 (Figure 5B). Study by Geraghty et
al. showed induction of the unfolded protein response via ATF4
mediated induction of C/EBP homologous protein CHOP in
primary small airway epithelial cells treated with cigarette smoke
extract [45]. Similar to our findings with acrolein treatment, acute
exposure to cigarette smoke of mice and guinea pigs led to
increased expression of CHOP [45].
While early induction of BIP and XBP-1 by acrolein may play
a role in triggering lung cell stress, chronic exposure to acrolein did
not affect the expression of these genes. Chronic acrolein
treatment induced activating transcription factor 4 (ATF4) and
C/EBP homologous protein (CHOP) as signals relating to lung
cell apoptosis. In the aggregate our data support the concept that
systemic application of acrolein, modeling circulating acrolein,
causes lung cell death. These data are similar to data obtained
after chronic exposure of rats to cigarette smoke; for example, Wu
et al. [46] reported an increased expression of lung tissue Bid,
cleaved caspase 3 and p53. Kelsen et al. showed that cigarette
smoke extract increases the expression of proteins associated with
the unfolded protein response in a human airway epithelial cell
line and speculated that the smoking-induced activation of the
unfolded protein response may serve as a protective mechanism
[43]. Although we find that acrolein increases the expression of
ATF4, consistent with the increased expression of ATF4 after
cigarette smoke exposure as reported by Kelsen et al. [43], the
concomitant large increase in CHOP and Gadd 34 mRNA after
acrolein exposure prompts us to propose that acrolein adminis-
tration had brought to the surface the aspect of the unfolded
protein response that accompanies the breakdown of the pro-
tective defenses of the lung tissue, leading to apoptosis and tissue
destruction.
Although we were surprised to find that the acutely acrolein-
induced lung cell death was not associated with a loss of lung tissue
VEGF expression (Figure 1B), this fact is not unprecedented and
supports our observation that acrolein induces ER stress; Pan et al.
showed in hepatoma cells that ER stress (likely via ATF4) increases
VEGF transcription [47], Roybal et al. showed increased VEGF
transcription in ER stressed retinal pigmented epithelial cells [48]
and Li et al. in tunicamycin-stressed retinal capillary endothelial
cells [49]. Whether VEGF – in the lungs from acrolein-treated
animals- is functional and signals effectively, among other actions,
via increased endothelial cell NO and prostacyclin production
remains to be investigated. Such concern is justified, because Nana
Sinkam et al. demonstrated that acrolein inhibits the expression of
the PGI2-synthase gene in human pulmonary microvascular
endothelial cells [50].
Our data also illustrate that, cigarette-smoke can trigger long-
lasting memory responses that persist beyond the immediate
period of exposure to cigarette smoke, in the form of acrolein-
protein adducts. While there are few acrolein-protein adducts the
healthy lungs (Figure 6D, 6E), acroleinated proteins are abun-
dantly labeled in a variety of cells from the lungs of COPD patients
(Figure 6A–C). These findings suggest that acrolein-protein adduct
Figure 4. TUNEL staining of rat lung sections. A. Control rat lung section, showing only oneTUNEL-positive intra-alveolar cell (arrow). B. Lung
section from a rat treated with 3 injections of 24 mmol/kg acrolein shows abundant TUNEL
+ cells in the alveolar septa (arrows). Magnification: 4006.
Scale bars=50 mm. C. Apoptotic index (AI) of TUNEL staining was performed as described in Materials and Methods. n=4 rats/per group, values are
mean6S.E. ** P,0.01 compared with control rat group.
doi:10.1371/journal.pone.0038038.g004
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the pathogenesis of emphysema.
There are many unsaturated aldehydes in cigarette smoke.
Along with acrolein, crotonaldehyde [51] is also accountable for
the stimulating effects on cytokine release from pulmonary cells.
Acrolein and crotonaldehyde effects are also mimicked by an
endogenous highly reactive compound 4-hydroxy-nonenal. This
latter substance is an unselective cation channel TRPA1 receptor
activator and also an abundant lipid peroxidation end-product
found in the lung of COPD patients [52]. Interestingly, 4-hydroxy-
nonenal lung adduct level correlated with severity of COPD [52].
Further studies are needed to demonstrate whether other un-
saturated aldehydes may cooperate with acrolein in producing
human lung emphysema.
Materials and Methods
Animals (Acute and chronic systemic acrolein challenge)
All animal use procedures were in strict accordance with the
National Institute of Health Guidelines for the Care and Use of
Laboratory Animals (IACUC) and approved by the Virginia
Commonwealth University’s Institutional Animal Care and Use
Committee. Male Sprague-Dawley rats, 6 weeks of age were
purchased from Harlan (Indianapolis, IN). The animals n=4 per
group were treated with intraperitoneal injections (i.p.) of PBS
(control group) or acrolein (in PBS, treatment groups). Acrolein
was purchased from Sigma-Aldrich Co. (St Louis, Missouri, USA).
Acute acrolein challenge. Twenty four rats were divided
into 6 groups. The control group was injected with 900 ml of PBS
1 hour prior to sacrifice. All other animals received a single i.p.
injection of 12 mmol/kg acrolein solution and were sacrificed 1, 2,
4 or 24 hours after the acrolein challenge.
Chronic acrolein challenge. Rats were divided into 4
groups: Group 1: control group (PBS injection), Group 2:
6 mmol/kg acrolein, Group 3: 12 mmol/kg acrolein, and Group
4: 24 mmol/kg acrolein. The injections were administered in-
traperitoneally on day 1, 8 and 15. Animals were sacrificed on day
21 after the first injection.
Tissue processing
After completion of the treatment period the rats were
anesthetized with a lethal dose of pentobarbital (NembutalH).
The chest was opened and the cardiopulmonary block was quickly
isolated and excised. The right main bronchus was cross-clamped
and the left lung was filled with 0.5% low melting agarose in 10%
formalin at a constant pressure of 25 cm H2O, allowing for
homogenous and full expansion of the lung parenchyma [53]. The
lungs were then fixed in 10% formalin for 48 hours and paraffin-
embedded. Tissue sections from upper and lower lobes of the left
lung were used for histological analysis.
Morphological assessment
The 5-mm paraffin-embedded lung tissue sections were stained
with hematoxylin and eosin (HE). 10 random lung fields per tissue
Figure 5. Immunohistochemistry for cleaved caspase 3 counterstained with hematoxylin. A. Control rat lung, showing a few caspase 3
positive cells in the alveolar septa (arrows). B. Lung tissue section from a set of treated with 12 mmol/kg acrolein, showing caspase 3 positive cells in
the alveolar septa (arrows). Magnification: 4006. Scale bars=50 mm. C. The apoptotic Index (AI) of immunohistochemistry for cleaved caspase 3 was
calculated as described in Materials and Methods. D. Western blot analysis of cleaved caspase 3 protein in the lung tissue extracts. n=4 rats/per
group, values are mean6S.E. *P,0.05 and **P,0.01 when compared to the control group.
doi:10.1371/journal.pone.0038038.g005
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color camera (Carl Zeiss MicroImaging Inc., Thornwood, New
York, USA). AxioVisionH Imaging System software (Carl Zeiss
MicroImaging Inc.) was used to measure the alveolar airspace
areas in pixels per mm
2. The mean alveolar airspace area of the
entire histological section of the lung was calculated using
a Microsoft Excel data spread sheet.
TUNEL staining
Terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labeling (TUNEL) was performed using the TACS 2 TdT
DAB kit (Trevigen, Gaithersburg, Maryland, USA), following the
manufacturer’s instructions. Briefly, after deparaffinization and
rehydration, sections were digested with proteinase K at a concen-
tration of 20 mg/ml for 15 minutes. Endogenous peroxidase
activity was quenched with 3% H2O2 for 5 minutes. The slides
were immersed in terminal deoxynucleotidyl transferase (TdT)
labeling buffer (Trevigen). TdT, 1 mM Mn
2+, and biotinylated
dNTP in TdT buffer were then added to cover the sections and
incubated in a humid atmosphere at 37uC for 60 minutes. The
slides were washed with PBS and incubated with streptavidin-
horseradish peroxidase for 10 minutes. After rinsing with PBS, the
slides were immersed in diaminobenzidine (DAB) solution
(Trevigen). The slides were counterstained for 1 minute with 1%
methyl green. To assess the apoptosis index of TUNEL stained
tissues, 10 random lung fields per tissue section were captured at
a 4006 magnification using the AxioCamH color camera (Carl
Zeiss MicroImaging Inc.) and the number of TUNEL-positive
cells was counted using the AxioVisionH Imaging System software
(Carl Zeiss MicroImaging Inc.). We focused on TUNEL-positive
alveolar septal cells and neglected alveolar macrophages. The
Figure 6. Western blot analysis of VEGF (A) and caspase 12 (B) in lung tissue homogenates from chronically acrolein injected rats.
The VEGF (dimer and monomer) protein expression was normalized to beta-actin. *P,0.05; **P,0.01 when compared to the control group.
doi:10.1371/journal.pone.0038038.g006
Figure 7. Quantitative real-time PCR analysis of Unfolded
Protein Response (UPR)-related gene expression in the 2
experimental rat groups (chronic challenge). n=4 rats/per group,
values are mean6S.E. **P,0.01 when compared to the control group.
doi:10.1371/journal.pone.0038038.g007
Acrolein and Emphysema
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e38038number of the TUNEL-positive alveolar septal cells was normal-
ized to the total number of cells in the lung tissue section.
Immunohistochemistry for caspase 3
Immunolocalization of apoptotic cells was performed on
paraffin-embedded, formalin-fixed rat lung sections using a rabbit
polyclonal antibody to cleaved caspase 3 (Cell signaling Technol-
ogy Inc., Beverly, Massachussets, USA). Briefly, after paraffin
removal in xylene, the sections were rehydrated and were placed
on a plastic container filled with Target Retrieval Solution Citrate
pH 6 (Dako, Glostrup, Denmark) and heated in a pressure cooker
for 10 minutes after it reached the highest pressure at 125uC. After
quenching of endogenous peroxidase with 3% of H2O2 for
15 minutes, the sections were incubated with rabbit polyclonal
antibody to cleaved caspase 3 (1:200 dilution) for 60 minutes at
room temperature. Immunodetection was performed using
biotinylated anti-rabbit IgG and peroxidase-conjugated streptavi-
din (Vector Laboratories, Burlingame, California, USA), with
diaminobenzidine (DAB) as the substrate. The slides were
counterstained for 30 seconds with hematoxylin.
Caspase-3 positive cells were counted in 10 randomly picked
lung fields per tissue section at a 4006 magnification using the
AxioCamH color camera (Carl Zeiss MicroImaging Inc.) and
Apoptotic Index (AI) was calculated as number of caspase-3
positive cells over the total length of alveolar perimeter measured
by the AxioVisionH Imaging System software (Carl Zeiss
MicroImaging Inc.).
Lung tissue homogenates
The right lung was homogenized immediately after isolation in
a buffer containing 150 mM of NaCl, 20 mM of Tris-HCl, 10% of
Glycerol, 1% of Igepal CA-630, 1 mg/ml of EDTA, 1 mM of
PMSF, 10 mg/ml of Aporotinin, 10 mg/ml of phosphatase in-
hibitor cocktail (contains L-isozymes of alkaline phosphatase and
threonine protein phosphatases (Sigma-Aldrich, Saint Louis,
Missouri, USA)), and 1 tablet of protein inhibitor cocktail (contains
inhibitors with a broad specificity for aminopeptidases, serine,
cystine, an acid proteases (Sigma-Aldrich)). Lung tissue homo-
genates were centrifuged at 10000 g for 15 minutes, and then
Figure 8. Acrolein-protein adducts in COPD (A–C) and healthy (D, E) lungs. In COPD lungs there is an abundant presence of acroleinated
proteins in endothelial and smooth muscle cells of the small vessels (A), bronchoepithelial cells (B), and inflammatory cells (C). The enlarged section
(C) shows intense staining of alveolar macrophages. Immunohistochemistry was performed on paraffin-embedded lung sections using a rabbit
polyclonal anti-acrolein antibody (Novus Biologicals). There are very few acrolein-protein adducts in healthy lungs (D, E).
doi:10.1371/journal.pone.0038038.g008
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Western blot analysis.
Western blot analysis
Proteins (30 mg) were subjected to electrophoresis on 4–12%
gradient Bio-Tris gels (Novex, San Diego, California, USA) and
transferred to PolyScreen PVDF Transfer Membrane (NEN Life
Science Products Inc., Boston, Massachusetts, USA) in Tris-
glycine buffer containing 10% methanol. Prestained molecular
mass marker proteins (Bio-Rad Laboratories Inc.) were used as
standards for the SDS-PAGE. Western blots were visualized using
Renaissance Western Blot Chemiluminescence Reagent (NEN
Life Science Products Inc.). Antibodies used: caspase 3 (Cell
signaling Inc.), VEGF (Santa Cruz Biotechnology Inc., Santa
Cruz, California, USA), caspase 12 (Santa Cruz Biotechnology
Inc.), b -Actin, anti-rabbit, anti-rat and anti-mouse HRP-
conjugated antibodies (Santa Cruz Biotechnology Inc.).
Real-time quantitative PCR (QPCR) for ER stress markers
Total RNA was extracted from rat lungs and purified using TRI
Reagent-LS (Molecular Research Center, Inc., Cincinnati, Ohio,
USA) according to the manufacturer’s specifications. 1 mg of total
RNA was reverse transcribed using the Thermoscript RT-PCR
system. Complementary DNA (cDNA) was diluted (1:500) and
real-time QPCR performed using Power SYBR Green QPCR
Master Mix (Applied Biosistems, Foster City, California, USA)
along with ER stress-related genes (the transcription factor ATF4,
binding immunoglobulin protein (a chaperone) BiP, cytosine-
cytosine-adenine-adenine-thymine enhancer-binding protein ho-
mologous protein CHOP; ER degradation-enhancing alpha-
mannosidase-like protein EDEM; growth arrest and DNA damage
gene Gadd 34, and X-box binding protein-1 spliced (XBP-1s) and
unspliced (XBP-1un) forms; (ATF4, BiP, CHOP, EDEM, Gadd
34, XBP-1s and XBP-1un), as well as VEGF and b-actin primers.
Cycling parameters were as follows: 95uC, 10 minutes and 40
cycles of 95uC for 15 seconds and 60uC for 1 minute. A
dissociation profile was generated after each run to verify
specificity of amplification. All PCR assays were performed in
triplicate. No template controls (NTC) and no reverse transcrip-
tase controls (No RT) were included. b-Actin was used as
a housekeeping gene against which all the samples were
normalized for differences in the quantity of total RNA added to
each cDNA reaction and for variation in the reverse transcriptase
efficiency among the different cDNA reactions. Automated gene
expression analysis was performed using the comparative quan-
titation module of MxPro QPCR Software (Stratagene, La Jolla,
California, USA). The levels of a target gene in test samples were
expressed relative to a sample of reference.
Human subjects and immunohistochemical detection of
acrolein-protein adducts
Human tissue was obtained from the University of Colorado
Hospital Department of Pathology. Informed consent to use the
tissue for research purposes had previously been obtained. Unused
transplant donor lungs without evidence of pulmonary disease
served as controls. Lungs from three patients with GOLD stage 3–
4 and five control lungs were studied. Acrolein-protein adducts in
the paraffin embedded lung tissue sections were detected by
immunohistochemistry using 2 different antibodies: polyclonal
antibody from Novus Biologicals (Littleton, CO) and monoclonal
antibody from Abcam (Cambridge, MA) according the manufac-
tures protocols. Both antibodies showed very similar results.
Statistical analysis
The data were expressed as mean 6 SEM. Statistical analysis
was performed with the Statview software package (SAS Institute
Inc., Cary, N Carolina, USA). The data were normally
distributed, and values obtained in the different groups of rats
were compared using one-way ANOVA. Statistical difference was
accepted at P,0.05.
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